J&J-Johnson & Johnson said Tuesday it plans to separate its artificial hip and knee business into a stand-alone company to be called DePuy Synthes

Johnson & Johnson said Tuesday it plans to separate its artificial hip and knee business into a stand-alone company to be called DePuy Synthes

强生(US:JNJ) WSJ·2025-10-14 18:20

公司战略 - 公司计划进行业务分拆是其近年来精简架构的最新举措 [1] - 公司战略目标聚焦于增长更快的业务板块 [1]